The loss of sphere-forming capacity and efficacy of tumour formation for CD24- MM cells can be linked to their loss of several other stemness markers, including CD47, EpCAM and OCT4, as shown for the tumour tissue. This evidence concerns the gene CD47 and Miyoshi myopathy.